|
🐜
|
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
14 auth.
Weihong Liu,
A. Putnam,
Xu-yu Zhou,
G. Szot,
Michael R. Lee,
Shirley Zhu,
P. Gottlieb,
P. Kapranov,
T. Gingeras,
Barbara Fazekas de St. Groth,
...
C. Clayberger,
David M. Soper,
S. Ziegler,
J. Bluestone
|
11 |
2006 |
11
🐜
|
|
🐜
|
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
11 auth.
J. Wenzlau,
K. Juhl,
Liping Yu,
O. Moua,
S. Sarkar,
P. Gottlieb,
...
M. Rewers,
G. Eisenbarth,
J. Jensen,
H. Davidson,
J. Hutton
|
9 |
2007 |
9
🐜
|
|
🐜
|
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
17 auth.
M. Pescovitz,
C. Greenbaum,
H. Krause-Steinrauf,
D. Becker,
S. Gitelman,
R. Goland,
P. Gottlieb,
J. Marks,
P. McGee,
A. Moran,
...
P. Raskin,
H. Rodriguez,
D. Schatz,
D. Wherrett,
Darrell M. Wilson,
J. Lachin,
J. Skyler
|
9 |
2009 |
9
🐜
|
|
🐜
|
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
16 auth.
R. Insel,
J. Dunne,
M. Atkinson,
Jane L. Chiang,
D. Dabelea,
P. Gottlieb,
C. Greenbaum,
K. Herold,
J. Krischer,
Å. Lernmark,
...
R. Ratner,
M. Rewers,
D. Schatz,
J. Skyler,
J. Sosenko,
A. Ziegler
|
9 |
2015 |
9
🐜
|
|
🐜
|
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
19 auth.
T. Orbán,
B. Bundy,
D. Becker,
L. Dimeglio,
S. Gitelman,
R. Goland,
P. Gottlieb,
C. Greenbaum,
J. Marks,
R. Monzavi,
...
A. Moran,
P. Raskin,
H. Rodriguez,
W. Russell,
D. Schatz,
D. Wherrett,
Darrell M. Wilson,
J. Krischer,
J. Skyler
|
8 |
2011 |
8
🐜
|
|
🐜
|
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
20 auth.
D. Wherrett,
B. Bundy,
D. Becker,
L. Dimeglio,
S. Gitelman,
R. Goland,
P. Gottlieb,
C. Greenbaum,
K. Herold,
J. Marks,
...
R. Monzavi,
A. Moran,
T. Orbán,
J. Palmer,
P. Raskin,
H. Rodriguez,
D. Schatz,
Darrell M. Wilson,
J. Krischer,
J. Skyler
|
8 |
2011 |
8
🐜
|
|
🐜
|
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial
13 auth.
K. Herold,
S. Gitelman,
M. Ehlers,
P. Gottlieb,
C. Greenbaum,
W. Hagopian,
Karen D. Boyle,
L. Keyes‐Elstein,
S. Aggarwal,
D. Phippard,
...
P. Sayre,
J. Mcnamara,
J. Bluestone
|
8 |
2013 |
8
🐜
|
|
🐜
|
Fall in C-Peptide During First 2 Years From Diagnosis
13 auth.
C. Greenbaum,
C. Beam,
D. Boulware,
S. Gitelman,
P. Gottlieb,
K. Herold,
J. Lachin,
P. McGee,
J. Palmer,
M. Pescovitz,
...
H. Krause-Steinrauf,
J. Skyler,
J. Sosenko
|
8 |
2012 |
8
🐜
|
|
🐜
|
Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells1
7 auth.
E. Bradshaw,
K. Raddassi,
W. Elyaman,
T. Orbán,
P. Gottlieb,
S. Kent,
...
D. Hafler
|
8 |
2009 |
8
🐜
|
|
🐬
|
Testing the NKT cell hypothesis of human IDDM pathogenesis.
Peter T. Lee,
A. Putnam,
K. Benlagha,
L. Teyton,
P. Gottlieb,
A. Bendelac
|
8 |
2002 |
8
🐬
|
|
🐜
|
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
11 auth.
T. Brusko,
C. Wasserfall,
Kieran M Mcgrail,
R. Schatz,
Hilla-Lee Viener,
D. Schatz,
...
M. Haller,
Jennifer E. P. Rockell,
P. Gottlieb,
M. Clare-Salzler,
M. Atkinson
|
7 |
2007 |
7
🐜
|
|
🐜
|
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
36 auth.
M. Battaglia,
Simi T. Ahmed,
Mark S. Anderson,
M. Atkinson,
D. Becker,
P. Bingley,
E. Bosi,
T. Brusko,
L. Dimeglio,
C. Evans-Molina,
S. Gitelman,
C. Greenbaum,
P. Gottlieb,
K. Herold,
M. Hessner,
...
M. Knip,
Laura M. Jacobsen,
J. Krischer,
S. A. Long,
M. Lundgren,
E. McKinney,
Noel G. Morgan,
Noel G. Morgan,
R. Oram,
R. Oram,
T. Pastinen,
M. Peters,
A. Petrelli,
Xiaoning Qian,
M. Redondo,
B. Roep,
B. Roep,
D. Schatz,
D. Skibinski,
M. Peakman,
M. Peakman
|
7 |
2019 |
7
🐜
|
